POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
PR Newswire•12/10/2026•08:00 ET
3
Key Highlights
- ➤POM (POM) targets predictive healthcare using AI, wearables, RPM and real-world data
- ➤Pomdoctor plans coordinated AI-driven monitoring, physician follow-up and personalized health management
- ➤Company is developing predictive healthcare data and services infrastructure
- ➤Strategy focuses on proactive intervention, particularly for chronic disease management
Expert Statements
Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor
“For generations, healthcare has largely focused on treating patients after illness or symptoms appear. New technologies are creating the opportunity to move healthcare intervention further upstream. We believe predictive healthcare will become an increasingly important part of future health management. By combining our healthcare operations, physician resources, real-world data and technology capabilities, we aim to help build the infrastructure needed to support this transition.”
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare PR Newswire
GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today highlighted its strategy to participate in the ongoing transformation of healthcare from a traditionally reactive model centered on treating illness after it occurs toward a more predictive and proactive approach to health management.
Get started
Create a free account to read the full story.